Accessibility Menu
Abcam logo

Abcam(LSE) ABC

This security has been delisted. This page is retained for historical reference.

ABC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

ABC Financials

Key Financial Metrics (TTM)

Gross Margin

71.21%

Operating Margin

2.03%

Net Income Margin

1.40%

Return on Equity

0.76%

Return on Capital

0.72%

Return on Assets

0.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

£226.75M

Operating Income

£35.78M

EBITDA

£65.90M

Operating Cash Flow

£82.35M

Capital Expenditure

-£46.98M

Free Cash Flow

£35.38M

Cash & ST Invst.

£109.60M

Total Debt

£229.90M

Abcam Performance Analysis

Abcam annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31GBP 462,900,000N/A
20222022-12-31GBP 361,700,000-21.9%
20232023-12-31GBP 383,500,0006.0%
20242024-12-31GBP 236,000,000-38.5%
Abcam sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42020-06-300.0%
Q22021-06-30N/A
Q42021-12-31N/A
Q22022-06-30N/A
Abcam annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31GBP 0.08N/A
20222022-12-31GBP -0.04N/A
Abcam sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42020-06-30-72.6%
Q22021-06-30N/A
Q42021-12-31N/A
Q22022-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2019YOY CHG

Revenue

£65.00M

+11.5%

Gross Profit

£45.05M

+10.6%

Gross Margin

69.31%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

1,682

N/A

Net Income

£3.13M

-79.9%

EBITDA

£9.95M

-51.5%

Quarterly Fundamentals

Name
Q4 2019YOY CHG

Total Cash

£109.60M

-48.3%

Total Debt

£229.90M

+96.5%

Accounts Receivable

£0.00

N/A

Inventory

£57.50M

+32.5%

Long Term Debt

£96.50M

-12.2%

Short Term Debt

£133.40M

+1778.9%

Return on Assets

0.45%

N/A

Return on Invested Capital

0.80%

N/A

Free Cash Flow

£6.83M

+5.4%

Operating Cash Flow

£15.75M

-0.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDC.LMediclinic International plc
£5.01+0.10%
C4XD.LC4X Discovery Holdings plc
£0.12+27.32%
ERGO.LErgomed plc
£13.48+0.15%
MTPH.LMidatech Pharma plc
£0.18+1794.74%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.20+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.21-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$63.71-0.00%
RIGTransocean
$5.29-0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.